Cargando…

Attenuating NF-κB/VCAM-1 Expression in the Middle Cerebral Artery Occlusion Model by Viola Odorata: Protection Against Ischemia-Reperfusion Injury in Rats

INTRODUCTION: The death of neurons and cerebral edema are the main consequences of stroke. However, inflammatory processes play key roles in aggravating cerebral damage following a stroke. This study aimed to investigate the effects of Viola odorata extract (VOE) on the infarct volume (IV), neurolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimifar, Kiana, Alipanah, Hiva, Solatani Hekmat, Ava, Bigdeli, Mohammad Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Neuroscience Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706287/
https://www.ncbi.nlm.nih.gov/pubmed/36457883
http://dx.doi.org/10.32598/bcn.12.6.2061.1
_version_ 1784840479956795392
author Karimifar, Kiana
Alipanah, Hiva
Solatani Hekmat, Ava
Bigdeli, Mohammad Reza
author_facet Karimifar, Kiana
Alipanah, Hiva
Solatani Hekmat, Ava
Bigdeli, Mohammad Reza
author_sort Karimifar, Kiana
collection PubMed
description INTRODUCTION: The death of neurons and cerebral edema are the main consequences of stroke. However, inflammatory processes play key roles in aggravating cerebral damage following a stroke. This study aimed to investigate the effects of Viola odorata extract (VOE) on the infarct volume (IV), neurologic deficits (ND), and the expression of NF-κB and VCAM-1 in the Middle Cerebral Artery Occlusion (MCAO) model. METHODS: The animals were randomly separated into 6 groups: (1) control group, (2) vehicle-treated group, (3) MCAO group, (4) VOE25 group, (5) VOE50 group, and (6) VOE75 group (n= 12). VOE (25, 50, and 75 mg/kg) and distilled water were administered daily for 30 days. Two hours after the last gavage, the rats were exposed to MCAO for 60 minutes. Twenty-four hours later, IV, ND, and NF-κB/VCAM-1 expressions were evaluated. RESULTS: Viola odorata extract exhibited excellent neuroprotective effects by reducing IV (mainly in the core and subcortex areas), and induced downregulation of NF-κB and VCAM-1 expression. CONCLUSION: Viola odorata could also activate intracellular pathways, reducing the expression of NF-κB and VCAM-1. It is useful for developing a novel medical herb for treating cerebral ischemia. HIGHLIGHTS: A stroke occurs when the blood supply to a part of the brain is interrupted or reduced. Viola odorata extract (VOE) reduced the infarct volumes (IV) in rats’ brains 24 h after middle cerebral artery occlusion (MCAO). VOE may decrease IV in the MCAO model by downregulating the NF-κB/VCAM-1 expression. PLAIN LANGUAGE SUMMARY: A stroke is a medical condition in which poor blood flow to the brain results in cell death. After an interruption of blood flow, energy stores are rapidly depleted, and complex cellular cascades induce excitotoxic cell death. So far, no effective and specific treatment has been suggested for the stroke. In this study, the neuroprotective effects of the viola odorata extract (VOE) were screened. The V. odorata extract exhibited excellent neuroprotective effects by reducing infarct volume and inducing downregulation of NF-κB/VCAM-1 expression. This finding suggests that V. odorata may be useful for developing a novel medical herb for treating cerebral ischemia.
format Online
Article
Text
id pubmed-9706287
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Iranian Neuroscience Society
record_format MEDLINE/PubMed
spelling pubmed-97062872022-11-30 Attenuating NF-κB/VCAM-1 Expression in the Middle Cerebral Artery Occlusion Model by Viola Odorata: Protection Against Ischemia-Reperfusion Injury in Rats Karimifar, Kiana Alipanah, Hiva Solatani Hekmat, Ava Bigdeli, Mohammad Reza Basic Clin Neurosci Research Paper INTRODUCTION: The death of neurons and cerebral edema are the main consequences of stroke. However, inflammatory processes play key roles in aggravating cerebral damage following a stroke. This study aimed to investigate the effects of Viola odorata extract (VOE) on the infarct volume (IV), neurologic deficits (ND), and the expression of NF-κB and VCAM-1 in the Middle Cerebral Artery Occlusion (MCAO) model. METHODS: The animals were randomly separated into 6 groups: (1) control group, (2) vehicle-treated group, (3) MCAO group, (4) VOE25 group, (5) VOE50 group, and (6) VOE75 group (n= 12). VOE (25, 50, and 75 mg/kg) and distilled water were administered daily for 30 days. Two hours after the last gavage, the rats were exposed to MCAO for 60 minutes. Twenty-four hours later, IV, ND, and NF-κB/VCAM-1 expressions were evaluated. RESULTS: Viola odorata extract exhibited excellent neuroprotective effects by reducing IV (mainly in the core and subcortex areas), and induced downregulation of NF-κB and VCAM-1 expression. CONCLUSION: Viola odorata could also activate intracellular pathways, reducing the expression of NF-κB and VCAM-1. It is useful for developing a novel medical herb for treating cerebral ischemia. HIGHLIGHTS: A stroke occurs when the blood supply to a part of the brain is interrupted or reduced. Viola odorata extract (VOE) reduced the infarct volumes (IV) in rats’ brains 24 h after middle cerebral artery occlusion (MCAO). VOE may decrease IV in the MCAO model by downregulating the NF-κB/VCAM-1 expression. PLAIN LANGUAGE SUMMARY: A stroke is a medical condition in which poor blood flow to the brain results in cell death. After an interruption of blood flow, energy stores are rapidly depleted, and complex cellular cascades induce excitotoxic cell death. So far, no effective and specific treatment has been suggested for the stroke. In this study, the neuroprotective effects of the viola odorata extract (VOE) were screened. The V. odorata extract exhibited excellent neuroprotective effects by reducing infarct volume and inducing downregulation of NF-κB/VCAM-1 expression. This finding suggests that V. odorata may be useful for developing a novel medical herb for treating cerebral ischemia. Iranian Neuroscience Society 2022 2022-05-01 /pmc/articles/PMC9706287/ /pubmed/36457883 http://dx.doi.org/10.32598/bcn.12.6.2061.1 Text en Copyright© 2022 Iranian Neuroscience Society https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Research Paper
Karimifar, Kiana
Alipanah, Hiva
Solatani Hekmat, Ava
Bigdeli, Mohammad Reza
Attenuating NF-κB/VCAM-1 Expression in the Middle Cerebral Artery Occlusion Model by Viola Odorata: Protection Against Ischemia-Reperfusion Injury in Rats
title Attenuating NF-κB/VCAM-1 Expression in the Middle Cerebral Artery Occlusion Model by Viola Odorata: Protection Against Ischemia-Reperfusion Injury in Rats
title_full Attenuating NF-κB/VCAM-1 Expression in the Middle Cerebral Artery Occlusion Model by Viola Odorata: Protection Against Ischemia-Reperfusion Injury in Rats
title_fullStr Attenuating NF-κB/VCAM-1 Expression in the Middle Cerebral Artery Occlusion Model by Viola Odorata: Protection Against Ischemia-Reperfusion Injury in Rats
title_full_unstemmed Attenuating NF-κB/VCAM-1 Expression in the Middle Cerebral Artery Occlusion Model by Viola Odorata: Protection Against Ischemia-Reperfusion Injury in Rats
title_short Attenuating NF-κB/VCAM-1 Expression in the Middle Cerebral Artery Occlusion Model by Viola Odorata: Protection Against Ischemia-Reperfusion Injury in Rats
title_sort attenuating nf-κb/vcam-1 expression in the middle cerebral artery occlusion model by viola odorata: protection against ischemia-reperfusion injury in rats
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706287/
https://www.ncbi.nlm.nih.gov/pubmed/36457883
http://dx.doi.org/10.32598/bcn.12.6.2061.1
work_keys_str_mv AT karimifarkiana attenuatingnfkbvcam1expressioninthemiddlecerebralarteryocclusionmodelbyviolaodorataprotectionagainstischemiareperfusioninjuryinrats
AT alipanahhiva attenuatingnfkbvcam1expressioninthemiddlecerebralarteryocclusionmodelbyviolaodorataprotectionagainstischemiareperfusioninjuryinrats
AT solatanihekmatava attenuatingnfkbvcam1expressioninthemiddlecerebralarteryocclusionmodelbyviolaodorataprotectionagainstischemiareperfusioninjuryinrats
AT bigdelimohammadreza attenuatingnfkbvcam1expressioninthemiddlecerebralarteryocclusionmodelbyviolaodorataprotectionagainstischemiareperfusioninjuryinrats